ThatcherRossHeumannMD

Oncology • Nashville, TN

Physician

Join to view full profile

Dr. Heumann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heumann's full profile

Already have an account?

Office
2220 Pierce Ave
Suite 798 Preston Research Building
Nashville, TN 37232
Phone+1 615-936-8422

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2019 - 2022
New York Downtown HospitalResidency, Internal Medicine, 2017 - 2019
NYU Grossman School of MedicineResidency, Internal Medicine, 2016 - 2019
Emory University School of MedicineClass of 2016

Certifications & Licensure

TN State Medical License 2022 - 2026
MD State Medical License 2020 - 2022
NY State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

46 citations
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.
Keyu Li, Joseph A Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim
Cancer Cell. 2022-11-14
13 citations
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies.
Justin H Lo, Rajiv Agarwal, Laura W Goff, Thatcher R Heumann
Cancers. 2023-06-23
17 citations
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectabl...
Thatcher Heumann, Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare
Nature Communications. 2023-06-20

Lectures

First-line stereotactic radiosurgery combined with systemic targeted and immune checkpoint inhibitor therapy in melanoma patients with newly diagnosed brain metastases.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Is There a Role for DOAC Level Monitoring in Clinical Practice?April 9th, 2019